Erratum to: PATTERNS AND FACTORS ASSOCIATED WITH LOW ADHERENCE TO PSYCHOTROPIC MEDICATIONS DURING PREGNANCY-A CROSS-SECTIONAL, MULTINATIONAL WEB-BASED STUDY: Adherence to Psychotropic Medications during Pregnancy (Depression and Anxiety, (2015), 32, 6, (426-436), 10.1002/da.22352);Patterns and factors associated with low adherence to psychotropic medications during pregnancy - A cross-sectional, multinational web-based study

Depression and Anxiety

Volumn 32, Issue 6, 2015, Pages 426-436

  Lupattelli, Angela ^a   Spigset, Olav ^b,c   Björnsdõttir, Ingunn ^a   Hämeen Anttila, Katri ^d   Mårdby, Ann Charlotte ^e   Panchaud, Alice ^f   Juraski, Romana Gjergja ^g   Rudolf, Gorazd ^h   Odalovic, Marina ⁱ   Drozd, Mariola ^j   Twigg, Michael J ^k   Juch, Herbert ^l   Moretti, Myla E ^m   Kennedy, Debra ⁿ   Rieutord, Andre ^o   Zagorodnikova, Ksenia ^p   Passier, Anneke ^q   Nordeng, Hedvig ^a,r  

^a UNIVERSITY OF OSLO   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d Finnish Medicines Agency   (Finland)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF GENEVA   (Switzerland)

^g SREBRNJAK CHILDREN S HOSPITAL   (Croatia)

^h UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

ⁱ UNIVERSITY OF BELGRADE   (Serbia)

^j MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^k UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^l MEDICAL UNIVERSITY OF GRAZ   (Austria)

^m HOSPITAL FOR SICK CHILDREN   (Canada)

ⁿ ROYAL HOSPITAL FOR WOMEN   (Australia)

^o ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^p NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

^q Netherlands Pharmacovigilance Centre Lareb   (Netherlands)

^r NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

more..

Author keywords

adherence; antidepressants; anxiety; depression; pharmacotherapy; pregnancy

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; AUSTRALIA; BLOOD PRESSURE REGULATION; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; EDINBURGH POSTNATAL DEPRESSION SCALE; EUROPE; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; NORTH AMERICA; PILOT STUDY; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; ANXIETY DISORDERS; CLINICAL TRIAL; COMPARATIVE STUDY; CULTURAL ANTHROPOLOGY; CULTURAL FACTOR; DEPRESSIVE DISORDER; INTERNET; MENTAL DISORDERS; MULTICENTER STUDY; PREGNANCY COMPLICATIONS; PSYCHOLOGY; YOUNG ADULT;

ADULT; ANXIETY DISORDERS; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; CULTURE; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTERNET; MEDICATION ADHERENCE; MENTAL DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84929504965     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22838     Document Type: Erratum

References (57)

1. Stevens JR,. Schizophrenia: reproductive hormones and the brain. Am J Psychiatry 2002; 159: 713-719.
2. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T,. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005; 106: 1071-1083.
3. Hendrick V., Psychiatric Disorders in Pregnancy and the Postpartum: Principles and Treatment. Toto wa, NJ: Humana Press; 2006.
4. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR,. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103: 698-709.
5. Sutter-Dallay AL, Giaconne-Marcesche V, Glatigny-Dallay E, Verdoux H,. Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: a prospective survey of the MATQUID cohort. Eur Psychiatry 2004; 19: 459-463.
6. ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008; 111: 1101-1020.
7. Andrade SE, Raebel MA, Brown J, et al., Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198: 194. e1-5.
8. Bakker MK, Kolling P, van den Berg PB, de Walle HE, de Jong van den Berg LT,. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 2008; 65: 600-606.
9. Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M,. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2012; 32: 186-194.
10. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ,. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67: 1012-1024.
11. Alder J, Fink N, Bitzer J, Hosli I, Holzgreve W,. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med 2007; 20: 189-209.
12. Misri S, Kendrick K, Oberlander TF, et al., Antenatal depression and anxiety affect postpartum parenting stress: a longitudinal, prospective study. Can J Psychiatry 2010; 55: 222-228.
13. Nordeng H, Ystrøm E, Einarson A,. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 2010; 66: 207-214.
14. Misri S, Eng AB, Abizadeh J, Blackwell E, Spidel A, Oberlander TF,. Factors impacting decisions to decline or adhere to antidepressant medication in perinatal women with mood and anxiety disorders. Depress Anxiety 2013; 30: 1129-1136.
15. Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I,. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry 2011; 72: 979-985.
16. Sawicki E, Stewart K, Wong S, Leung L, Paul E, George J,. Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol 2011; 51: 333-338.
17. Lupattelli A, Spigset O, Nordeng H,. Adherence to medication for chronic disorders during pregnancy: results from a multinational study. Int J Clin Pharm 2014; 36: 145-153.
18. Cohen LS, Altshuler LL, Harlow BL, et al., Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. J Am Med Assoc 2006; 295: 499-507.
19. Lupattelli A, Spigset O, Twigg MJ, et al., Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open 2014; 4: e004365.
20. WHO Collaborating Centre for Drugs Statistics Methodology. ATC/DDD Index; 2012. Available at: http://www.whocc.no/atc-ddd-index/.
21. Morisky DE, Ang A, Krousel-Wood M, Ward HJ,. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10: 348-354.
22. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P,. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009; 15: 59-66.
23. Morisky DE, DiMatteo MR,. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 2011; 64: 255-257; discussion 258-263.
24. Dempster AP, Laird NM, Rubin DB,. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc B Stat Methodol 1977; 39: 1-38.
25. Cox J, Holden J, Sagovsky R,. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-786.
26. Cox JL, Holden J,. Perinatal Mental Health: A Guide to the Edinburgh Postnatal Depression Scale (EPDS). London, England: RCPsych Publications; 2003.
27. Department of Health. Edinburgh Postnatal Depression Scale (EPDS): Translated Versions-Validated. Perth, Western Australia: State Perinatal Mental Health Reference Group; 2006.
28. Tamminen T,. Postnatal depression, breastfeeding and mother-infant interaction. Unpublished doctoral thesis, University of Tampere: Tampere, Finland; 1990.
29. Grote V, Vik T, von Kries R, et al., Maternal postnatal depression and child growth: a European cohort study. BMC Pediatr 2010; 10: 14.
30. Stewart DE, Gagnon A, Saucier JF, Wahoush O, Dougherty G,. Postpartum depression symptoms in newcomers. Can J Psychiatry 2008; 53: 121-124.
31. Horne R, Weinman J, Hankins M,. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 14: 1-24.
32. Horne R, Weinman J,. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-567.
33. Argentero P, Torchio E, Tibaldi G, Horne R, Clatworthy J, Munizza C,. The beliefs about drug treatment. The Italian version of the BMQ (the Beliefs about Medicines Questionnaire): its validity and applicability. Epidemiol Psichiatr Soc 2010; 19: 86-92.
34. Gauchet A, Tarquinio C, Fischer G,. Psychosocial predictors of medication adherence among persons living with HIV. Int J Behav Med 2007; 14: 141-150.
35. Jonsdottir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA,. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand 2009; 119: 78-84.
36. Mahler C, Hermann K, Horne R, Jank S, Haefeli WE, Szecsenyi J,. Patients' beliefs about medicines in a primary care setting in Germany. J Eval Clin Pract 2012; 18: 409-413.
37. Mårdby AC, Akerlind I, Jorgensen T,. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns 2007; 69: 158-164.
38. Menckeberg TT, Bouvy ML, Bracke M, et al., Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 2008; 64: 47-54.
39. Grigoriadis S, VonderPorten EH, Mamisashvili L, et al., Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry 2013; 74: e293-e308.
40. Hardin JW, Hilbe J,. Generalized Estimating Equations. Boca Raton, FL: CRC Press; 2013.
41. Cronbach LJ., Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
42. Demyttenaere K., Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol 2003; 13 (Suppl 3): S69-S75.
43. ten Doesschate MC, Bockting CL, Schene AH,. Adherence to continuation and maintenance antidepressant use in recurrent depression. J Affect Disord 2009; 115: 167-170.
44. Grigoriadis S, VonderPorten EH, Mamisashvili L, et al., The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 2013; 74: e321-e341.
45. Koren G, Nordeng H,. Antidepressant use during pregnancy: the benefit-risk ratio. Am J Obstet Gynecol 2012; 207: 157-163.
46. Mulder E, Davis A, Gawley L, Bowen A, Einarson A,. Negative impact of non-evidence-based information received by women taking antidepressants during pregnancy from health care providers and others. J Obstet Gynaecol Can 2012; 34: 66-71.
47. Jasper JD, Goel R, Einarson A, Gallo M, Koren G,. Effects of framing on teratogenic risk perception in pregnant women. Lancet 2001; 358: 1237-1238.
48. Einarson A, Selby P, Koren G,. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 2001; 26: 44-48.
49. Serna MC, Cruz I, Real J, Gasco E, Galvan L,. Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. Eur Psychiatry 2010; 25: 206-213.
50. Chong WW, Aslani P, Chen TF,. Effectiveness of interventions to improve antidepressant medication adherence: a systematic review. Int J Clin Pract 2011; 65: 954-975.
51. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V,. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One 2013; 8: e80633.
52. Ekman A, Dickman P, Klint Å, Weiderpass E, Litton J-E,. Feasibility of using web-based questionnaires in large population-based epidemiological studies. Eur J Epidemiol 2006; 21: 103-111.
53. van Gelder MM, Bretveld RW, Roeleveld N,. Web-based questionnaires: the future in epidemiology? Am J Epidemiol 2010; 172: 1292-1298.
54. Seybert H., Internet use in households and by individuals in 2011. Eurostat Statistics in focus 2011. Available at: http://ec.europa.eu/eurostat/documents/3433488/5579964/KS-SF-11-066-EN.PDF/090e071f-c3a9-45d8-aa90-9b142251fd3a?version=1.0.
55. Australian Bureau of Statistics. Household Use of Information Technology, Australia, 2012-2013. Available at: http://www.abs.gov.au/ausstats/abs.nsf/Lookup/8146.0Chapter12012-13.
56. Statistics Canada. Individual Internet Use and E-commerce; 2010. Available at: http://www.statcan.gc.ca/daily-quotidien/111012/dq111012a-eng.htm.
57. United States Census Bureau. The 2012 Statistical Abstract. Information & Communications: Internet Publishing and Broadcasting and Internet Usage; 2010. Available at: http://www.census.gov/compendia/statab/cats/information-communications/internet-publishing-and-broadcasting-and-internet-usage.html.